Comparison of Beta-cryptoxanthin Bioavailability From Biofortified Maize in Humans
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to determine how well the body absorbs the carotenoid beta-cryptoxanthin (BCX) from a type of corn that has been naturally bred (not genetically engineered) to contain higher amounts of BCX than traditional breeds of corn. Because this new type of corn contains higher amounts of BCX, it appears more orange in color than traditional types of corn. Understanding how well the body can absorb the BCX from the corn may help companies develop food products that may have improved nutritional quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2016
CompletedFirst Posted
Study publicly available on registry
June 15, 2016
CompletedStudy Start
First participant enrolled
July 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 23, 2017
CompletedJanuary 24, 2019
January 1, 2019
4 months
June 7, 2016
January 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Serum beta-cryptoxanthin concentration area under the curve ((µmol/L)*t)
Serum beta-cryptoxanthin concentration area under the curve calculated from samples on days 0, 3, 6, 9, 12, 15, 19 of treatment phase
19 days with blood samples drawn on days 0, 3, 6, 9, 12, 15, 19 of treatment phase
Secondary Outcomes (4)
Serum retinol carbon-13 natural abundance (δ 13C‰)
19 days and will be measured on days 0, 12, and 19
Vitamin A total body stores (µmol vitamin A) by retinol isotope dilution
14 days and will include the final blood of phase three and another sample 14 days later
Vitamin A estimated total liver reserves (µmol vitamin A/g liver) by retinol isotope dilution
14 days and will include the final blood of phase three and another sample 14 days later
Serum zeaxanthin, lutein, and beta-carotene concentration area under the curves ((µmol/L)*t)
19 days with blood samples drawn on days 0, 3, 6, 9, 12, 15, 19 of treatment phase
Study Arms (3)
Whole grain high-BCX maize
EXPERIMENTALWhole grain, high-beta-cryptoxanthin (BCX; orange) maize will be incorporated into two muffins to be fed daily for 12 days. Complementary diet will be low in carotenoids.
Refined grain high-BCX maize
EXPERIMENTALRefined (degermed) grain, high-beta-cryptoxanthin (BCX; orange) maize will be incorporated into two muffins to be fed daily for 12 days. Complementary diet will be low in carotenoids.
Whole grain white maize
PLACEBO COMPARATORWhole grain, white maize (low in beta-cryptoxanthin) will be incorporated into two muffins to be fed daily for 12 days. Complementary diet will be low in carotenoids.
Interventions
The whole grain orange maize will be milled and prepared into muffins to be consumed daily. Muffins will contain a target of 500 µg beta-cryptoxanthin per day.
The refined grain orange maize will be degermed, milled, and prepared into muffins to be consumed daily. Muffins will contain a target of 500 µg beta-cryptoxanthin per day.
The whole grain white maize will be milled and prepared into muffins to be consumed daily. Muffins will contain minimal beta-cryptoxanthin, matched for dry maize weight.
Eligibility Criteria
You may qualify if:
- Age 20 - 28 y, BMI 19 - 26 kg/m2, non-smoking, not pregnant or trying to become pregnant, and not lactating.
You may not qualify if:
- Smoker
- BMI \< 19 kg/m\^2 or BMI \> 26 kg/m\^2
- Women: pregnant or trying to become pregnant, breast-feeding
- Weight loss greater than or equal to 10 pounds (4.5 kilograms) during the 3 months prior to recruitment
- Actively trying to lose weight
- Fat malabsorptive disorders
- Inability to refrain from drinking alcohol when requested
- Amenorrhea
- Acute or chronic illness, including hepatitis
- Current or previous history of anorexia or bulimia
- History of iron deficiency anemia
- Inability to pick up food from research facility and eat meals on site when requested
- Planned vacation of \>1 week duration during the study
- Known scheduling conflict with the blood draws
- Major food allergies/intolerance to ingredients used in the meals
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Madisonlead
- PepsiCo, Inc.collaborator
- CIMMYTcollaborator
Study Sites (1)
University of Wisconsin-Madison Nutritional Sciences
Madison, Wisconsin, 53706, United States
Related Publications (6)
Arscott SA, Simon PW, Tanumihardjo SA. Anthocyanins in purple-orange carrots (Daucus carota L.) do not influence the bioavailability of beta-carotene in young women. J Agric Food Chem. 2010 Mar 10;58(5):2877-81. doi: 10.1021/jf9041326.
PMID: 20131807BACKGROUNDHorvitz MA, Simon PW, Tanumihardjo SA. Lycopene and beta-carotene are bioavailable from lycopene 'red' carrots in humans. Eur J Clin Nutr. 2004 May;58(5):803-11. doi: 10.1038/sj.ejcn.1601880.
PMID: 15116084BACKGROUNDMolldrem KL, Li J, Simon PW, Tanumihardjo SA. Lutein and beta-carotene from lutein-containing yellow carrots are bioavailable in humans. Am J Clin Nutr. 2004 Jul;80(1):131-6. doi: 10.1093/ajcn/80.1.131.
PMID: 15213039BACKGROUNDTanumihardjo SA, Horvitz MA, Dosti MP, Simon PW. Serum alpha- and beta-carotene concentrations qualitatively respond to sustained carrot feeding. Exp Biol Med (Maywood). 2009 Nov;234(11):1280-6. doi: 10.3181/0903-RM-106. Epub 2009 Aug 5.
PMID: 19657072BACKGROUNDOsth M, Ost A, Kjolhede P, Stralfors P. The concentration of beta-carotene in human adipocytes, but not the whole-body adipocyte stores, is reduced in obesity. PLoS One. 2014 Jan 8;9(1):e85610. doi: 10.1371/journal.pone.0085610. eCollection 2014.
PMID: 24416432BACKGROUNDTitcomb TJ, Sheftel J, Sowa M, Gannon BM, Davis CR, Palacios-Rojas N, Tanumihardjo SA. beta-Cryptoxanthin and zeaxanthin are highly bioavailable from whole-grain and refined biofortified orange maize in humans with optimal vitamin A status: a randomized, crossover, placebo-controlled trial. Am J Clin Nutr. 2018 Oct 1;108(4):793-802. doi: 10.1093/ajcn/nqy134.
PMID: 30321275RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Sherry A Tanumihardjo, Ph.D.
University of Wisconsin, Madison
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2016
First Posted
June 15, 2016
Study Start
July 21, 2016
Primary Completion
November 14, 2016
Study Completion
October 23, 2017
Last Updated
January 24, 2019
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share